IRIS Institutional Research Information System - OPENBS Open Archive UniBS

RUSSO, DOMENICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.835
AS - Asia 15.869
EU - Europa 11.670
SA - Sud America 3.406
AF - Africa 402
OC - Oceania 58
Continente sconosciuto - Info sul continente non disponibili 27
Totale 58.267
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.340
SG - Singapore 5.452
CN - Cina 5.171
BR - Brasile 2.818
UA - Ucraina 2.782
IT - Italia 1.901
HK - Hong Kong 1.811
DE - Germania 1.609
PL - Polonia 1.094
VN - Vietnam 1.075
FI - Finlandia 949
FR - Francia 779
GB - Regno Unito 614
TR - Turchia 592
RU - Federazione Russa 562
BD - Bangladesh 502
IE - Irlanda 498
IN - India 452
SE - Svezia 310
CA - Canada 234
AR - Argentina 228
MX - Messico 146
IQ - Iraq 132
ZA - Sudafrica 122
ID - Indonesia 106
JP - Giappone 99
NL - Olanda 96
EC - Ecuador 93
ES - Italia 80
CZ - Repubblica Ceca 78
CO - Colombia 73
AT - Austria 71
SA - Arabia Saudita 59
BE - Belgio 57
UZ - Uzbekistan 56
VE - Venezuela 56
AU - Australia 55
PK - Pakistan 48
MA - Marocco 46
EG - Egitto 39
PY - Paraguay 38
MU - Mauritius 35
CL - Cile 33
PE - Perù 31
NG - Nigeria 30
AE - Emirati Arabi Uniti 28
JO - Giordania 28
KE - Kenya 28
EU - Europa 26
AZ - Azerbaigian 25
IL - Israele 25
JM - Giamaica 25
DZ - Algeria 22
TN - Tunisia 22
UY - Uruguay 22
PH - Filippine 20
CH - Svizzera 19
LT - Lituania 19
KR - Corea 18
NP - Nepal 18
OM - Oman 18
DK - Danimarca 17
ET - Etiopia 17
TH - Thailandia 16
IR - Iran 15
PA - Panama 15
RO - Romania 15
SN - Senegal 15
KG - Kirghizistan 14
MY - Malesia 14
DO - Repubblica Dominicana 13
GR - Grecia 12
HN - Honduras 12
AL - Albania 11
BO - Bolivia 11
HU - Ungheria 11
KZ - Kazakistan 11
PT - Portogallo 11
PS - Palestinian Territory 10
TT - Trinidad e Tobago 10
BA - Bosnia-Erzegovina 9
BG - Bulgaria 9
CR - Costa Rica 9
LB - Libano 9
MD - Moldavia 9
SK - Slovacchia (Repubblica Slovacca) 8
LK - Sri Lanka 7
LV - Lettonia 7
AM - Armenia 6
HR - Croazia 6
NI - Nicaragua 6
AO - Angola 5
BB - Barbados 5
BY - Bielorussia 5
RS - Serbia 5
SV - El Salvador 5
BH - Bahrain 4
CU - Cuba 4
EE - Estonia 4
GA - Gabon 4
Totale 58.191
Salva come PNG Salva come JPEG
Città #
Singapore 2.794
Woodbridge 2.462
Fairfield 2.431
Ashburn 2.218
Jacksonville 1.974
Hong Kong 1.807
Houston 1.792
Ann Arbor 1.355
Cambridge 1.085
Warsaw 1.075
San Jose 1.072
Wilmington 972
The Dalles 968
Seattle 959
Princeton 935
Beijing 827
Chandler 799
New York 748
Nanjing 657
Dublin 492
Helsinki 489
Los Angeles 488
Lauterbourg 479
Istanbul 437
Dallas 375
Ho Chi Minh City 354
Munich 334
Des Moines 326
Brescia 322
Nanchang 267
Milan 265
São Paulo 263
Hanoi 230
Shanghai 227
Buffalo 220
Moscow 192
Redondo Beach 177
Changsha 172
San Diego 168
Shenyang 166
San Francisco 151
Dearborn 148
Tianjin 143
Council Bluffs 134
Jinan 133
Hebei 129
Boardman 118
Orem 117
Santa Clara 117
Chicago 110
Jiaxing 109
Turku 108
London 101
Hangzhou 96
Rome 89
Tokyo 88
Brooklyn 83
Verona 80
Kunming 76
Rio de Janeiro 71
Nuremberg 70
Denver 69
Frankfurt am Main 69
Guangzhou 66
Chennai 65
Kocaeli 65
Toronto 65
Brasília 63
Atlanta 62
Johannesburg 60
Brno 59
Zhengzhou 58
Belo Horizonte 57
Brussels 56
Montreal 56
Curitiba 54
Phoenix 54
Pune 54
Boston 49
Ningbo 49
Romola 47
Tashkent 47
Baghdad 45
Stockholm 45
Lanzhou 44
Manchester 44
Haiphong 43
Mexico City 42
Poplar 41
Mumbai 37
Turin 37
Charlotte 36
Dong Ket 36
Da Nang 35
Norwalk 34
Salvador 34
Amsterdam 33
Jakarta 33
Campinas 31
Guarulhos 31
Totale 37.549
Salva come PNG Salva come JPEG
Nome #
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells) 326
BACTERIAL BLOOD STREAM INFECTIONS NEGATIVELY IMPACT ON OUTCOME OF PATIENTS TREATED WITH ALLOGENEIC STEM CELL TRANSPLANTATION: 6 YEARS SINGLE-CENTRE EXPERIENCE 295
Postremission sequential monitoring of minimal residual disease by WT1 Q-PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk-adapted therapy in acute myeloid leukemia patients 293
Circulating endothelial cell count: a reliable marker of endothelial damage in patients undergoing hematopoietic stem cell transplantation 271
Unraveling the complexity of tyrosine kinase inhibitor-resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain 268
A standardized flow cytometry network study for the assessment of circulating endothelial cell physiological ranges 264
“Variant-specific discrepancy when quantitating BCR-ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay.” Is dPCR the key? 249
Effects and outcome of a policy of intermittent imatinib treatment in elderly patients with chronic myeloid leukemia. 239
Zebrafish disease models in hematology: Highlights on biological and translational impact 236
Do chromosomal abnormalities show up during mesenchymal stromal cell expansion? 230
Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia 210
A specific Toll-like receptor profile on T lymphocytes and values of monocytes correlate with bacterial, fungal, and cytomegalovirus infections in the early period of allogeneic stem cell transplantation 209
3D gelatin-chitosan hybrid hydrogels combined with human platelet lysate highly support human mesenchymal stem cell proliferation and osteogenic differentiation 209
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria 203
Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years 198
Betaherpesvirus Reactivation and Toll-Like Receptor Expression After Allogeneic Stem Cell Transplantation. 190
Targeting HRASV12G Expression to the Zebrafish Early Hemogenic Progenitors Induces a Myeloproliferative Disorder by Repressing the Notch Pathway. 188
Rational Design and Development of Anisotropic and Mechanically Strong Gelatin-Based Stress Relaxing Hydrogels for Osteogenic/Chondrogenic Differentiation 186
Comparative Somatic Mutational Profiling of CD34+ Hematopoietic Precursors (HSC) and Circulating Endothelial Cells (CEC) in Patients with Primary Myelofibrosis (PMF) 186
EXPRESSION OF TOLL-LIKE RECEPTORS ON PERIPHERAL BLOOD CELLS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: ONGOING RESULTS OF A PROSPECTIVE STUDY. 184
Counting circulating endothelial cells in allo-HSCT: an ad hoc designed polychromatic flowcytometry-based panel versus the CellSearch System 182
A Gene Panel NGS-Based Strategy for Genomic Characterization of Acute Myeloid Leukemias (AMLs) 180
A first update on mapping the human genetic architecture of COVID-19 179
Profile of Toll-Like Receptors on Peripheral Blood Cells in Relation to Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation 178
Advances in CMV Management: A Single Center Real-Life Experience 177
Acute graft-versus-host disease and expression of Toll-like receptors on peripheral blood cells after allogeneic stem cell transplantation 174
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease 173
Central Venous Catheter-Related Bloodstream Infection Caused by Brevibacterium casei in a Hematology Patient 172
TARGETING HRASV12G EXPRESSION TO THE ZEBRAFISH EARLY HEMOGENIC PROGENITORS INDUCES A MYELOPROLIFERATIVE DISORDER BY REPRESSING THE NOTCH PATHWAY. 171
Multidimensional Geriatric Assessment for Elderly Patients (≥60 years) Submitted for Allogeneic Stem Cell Transplantation. a French (Paris) - Italian (Brescia) 10-Years Experience on 228 Patients 170
Expression of Toll-Like Receptors on Peripheral Blood Cells After Allogeneic Stem Cell Transplantation: Results of a Prospective Study. 169
Assessment of BCR-ABL1 Transcript Levels By Digital PCR (dPCR) in CML Patients who Achieved a Deep Molecular Response (DMR: MR4.0, MR4.5 And MR5.0) with Tkis May Improve the Detection of Minimal Residual Disease (MRD) and the Selection of Patients for Treatment Free Remission (TFR) 169
SIRPB1 Is a Strong Predictor Biomarker of Response to 5-Azacitidine Therapy in MDS and AML Patients 168
Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome 167
Development of BCR-ABL1 Transgenic Zebrafish Model Reproducing Chronic Myeloid Leukemia (CML) Like-Disease and Providing a New Insight into CML Mechanisms 165
Clinical Care of Hematological Patients in a Bone Marrow Transplant Unit: Do Human Resources Influence Infection Incidence? 164
Chitosan-Hydrogel Polymeric Scaffold Acts as an Independent Primary Inducer of Osteogenic Differentiation in Human Mesenchymal Stromal Cells 164
Fungemia in hematological malignancies: SEIFEM-2015 survey 163
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS 162
A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: retrospective analysis of 530 patients. 160
Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation 160
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review 158
Procoagulant cellular activity and disseminated intravascular coagulation in acute non-lymphoid leukaemia. 158
A prospective comparison of alpha-IFN and conventional chemotherapy in Ph+ chronic myeloid leukemia. Clinical and cytogenetic results at 2 years in 322 patients 157
Identification of a Novel Mutation Predisposing to Familial AML and MDS Syndrome By a NGS Approach 157
Intermittent Imatinib (INTERIM) Treatment of Patients with Ph+ Chronic Myeloid Leukemia in Complete Cytogenetic Response: Cytogenetic and Molecular Data At One Year. 156
MULTI-GENOTYPING OF MINOR HISTOCOMPATIBILITY ANTIGENS (MHAGS) IN ALLOGENEIC STEM CELL TRANSPLANTATION AND THEIR ROLE IN DETERMINING GRAFT VERSUS HOST DISEASE (GVHD) AND GRAFT VERSUS LEUKEMIA (GVL) EFFECT. 155
5-azacitidine five days/monthly schedule in symptomatic low-risk (IPSS: 0-1) myelodisplastic (MDS) patients. clinical and biological effects. 154
Central nervous system angiitis in Hodgkin's disease. 154
"Real-life' analysis of the role of antifungal prophylaxis in preventing invasive aspergillosis in AML patients undergoing consolidation therapy: Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) 2016 study 154
RT-qPCR versus Digital PCR: How Do They Impact Differently on Clinical Management of Chronic Myeloid Leukemia Patients? 154
Bioengineered scaffolding for mandibular reconstruction: a preclinical, xenograft animal study 154
Assessment of Liver Damage with Transient Hepatic Elastography (FIBROSCAN) in patients with chronic Graft-Versus-Host Disease. 152
Imatinib mesylate in the treatment of c-kit-positive acute myeloid leukemia: is this the real target? 152
PARAMETERS OF PROTEIN METABOLISM AND THYROID FUNCTION AS PREDICTORS OF A SCORING SYSTEM FOR ACUTE AND CHRONIC GRAFT-VERSUS-HOST DISEASE 152
Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatment 152
Screening of Bcr-Abl transcripts in Philadelphia negative essential thrombocythemia. 151
Targeting oncogene expression to endothelial cells induces proliferation of the myelo-erythroid lineage by repressing the notch pathway. 151
Development of a cell culture model based on biocompatible polymeric scaffolds engineered with human Mesenchymal Stromal Cells (MSCs) for cartilage and bone regenerative therapy 151
P-glycoprotein (PGP) and lung resistance-related protein (LRP) expression and function in leukaemic blast cells. 150
Peripheral Blood WT1 Expression Predicts Relapse in AML Patients Undergoing Allogeneic Stem Cell Transplantation. 150
First Interim Report of the Italian Multicentric Phase-III Randomized Study to Optimize TKIs Multiple Approaches - (OPTkIMA) in Elderly Patients (older than 60 years) with Ph+ Chronic Myeloid Leukemia (CML) and MR3.0/ MR4.0 Stable Molecular Response 150
Antilymphocyte globulin for prevention of chronic graft-versus-host disease 149
Baseline factors associated with response to ruxolitinib: An independent study on 408 patients with myelofibrosis 149
Single Cell Analysis of Circulating Endothelial Cells in Allogeneic Hematopoietic Stem Cell Transplant; To Whom Do They Belong: Host or Donor? 149
3D-MAPPING OF MESENCHYMAL STEM CELLS GROWTH ON BIOENGINEERED SCAFFOLDS FOR MAXILLOFACIAL SKELETON REGENERATION: A PRECLINICAL, IN VITRO STUDY 148
Impedance-based monitoring of mesenchymal stromal cell three-dimensional proliferation using aerosol jet printed sensors: A tissue engineering application 147
In chronic myeloid leukemia patients on second-line tyrosine kinase inhibitor therapy, deep sequencing of BCR-ABL1 at the time of warning may allow sensitive detection of emerging drug-resistant mutants 146
CT-290: Clinical Frailty Scale as a Novel Tool to Evaluate Patients’ Eligibility for Allogeneic Stem Cell Transplant: A Single-Center Experience on 234 Patients >50 Years Old 146
Different In Vitro Models of Chronic Myeloid Leukemia Show Different Characteristics: Biological Replicates Are Not Biologically Equivalent 145
Bone Marrow Stroma and Vascular Contributions to Myeloma Bone Homing 145
Procoagulant cellular activity and disseminated intravascular coagulation in acute non-lymphoid leukaemia 144
Concomitant ABCG2 overexpression and FLT3-ITD mutation identify a subset of acute myeloid leukemia patients at high risk of relapse 144
ANTI-CMV Immunoglobulins in Association with ANTI-CMV Drugs in Patients with Hematological Malignancies Submitted to Allogeneic STEM CELL Transplantation: A MULTI-Center Retrospective Experience 144
SHP-1 expression accounts for resistance to imatinib treatment in Philadelphia chromosome-positive cells derived from patients with chronic myeloid leukemia. 143
Parameters of Protein Metabolism and Thyroid Function As Predictors in a Scoring System for Acute and Chronic Graft-Versus-Host Disease 143
Venetoclax plus decitabine as a bridge to allogeneic haematopoietic stem-cell transplantation in older patients with acute myeloid leukaemia (VEN-DEC GITMO): final report of a multicentre, single-arm, phase 2 trial 142
Development of a Preclinical Double Model of Mandibular Irradiated Bone and Osteoradionecrosis in New Zealand Rabbits 141
A NEW PROMISING APPROACH TO PERFORM HLA TYPING IN A QUICKLY, SIMPLE AND ACCURATE WAY: THE PYROSEQUENCING 141
Digital PCR (Dpcr) a Step Forward to Detection and Quantification of Minimal Residual Disease (MRD) in Ph+/BCR-ABL1 Chronic Myeloid Leukemia (CML) 141
Multidimensional geriatric assessment for elderly hematological patients (≥60 years) submitted to allogeneic stem cell transplantation. A French-Italian 10-year experience on 228 patients 140
Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP) 139
Advances in the treatment of monoclonal gammapathies: the emerging role of targeted therapy in plasma cell dyscrasias. 139
Laboratory diagnostics of inherited platelet disorders. 139
INTEGRATED CORE-SHELL BIOACTIVE STRUCTURE FOR THE REGENERATION OF BONE AND OSTEOCHONDRAL TISSUES 139
A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: retrospective analysis of 530 patients. 138
Parameters of Protein Metabolism and Thyroid Function As Predictors in a Scoring System for Acute and Chronic Graft-Versus-Host Disease 138
Comparative Study on Fresenius-ATG Versus Thymoglobuline-ATG for the Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation from Matched Unrelated Donor: A Single Center Experience on 76 Patients 138
TRIDIMENSIONAL BIOACTIVE POROUS BODY FOR BONE TISSUE REGENERATION AND PROCESS FOR ITS PREPARATION 138
Sensitivity of chronic myeloid leukemia hemopoietic progenitors to PTT-119 in combination with human recombinant interferon alpha and gamma 137
Laparoscopic splenectomy in the management of hematological diseases 137
Is the New Tci Score Sufficient to Categorize the Intensity of Conditioning? a Single-Centre Study 136
Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients. 136
Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-kit positive acute myeloid leukemia. Results of an italian multicentric phase II study. 136
Case-control study of multidrug resistance phenotype and response to induction treatment including or not fludarabine in newly diagnosed acute myeloid leukaemia patients. 135
Long-term follow-up of the Italian trial of interferon- versus conventional chemotherapy in chronic myeloid leukemia 135
Rituximab in a case of cold agglutinin disease 135
Use of a high sensitive nanofluidic array for the detection of rare copies of BCR-ABL1 transcript in patients with Philadelphia-positive acute lymphoblastic leukemia in complete response. 135
Index of Bone Marrow Output and Imbalance of B-Lymphocyte Homeostasis before and after Transplantation Correlate Differently with Graft-Versus-Host Disease and Relapse 135
ETV6: A Candidate Gene for Predisposition to “Blend Pedigrees”? A Case Report from the NEXT-Famly Clinical Trial 135
Totale 16.770
Salva come PNG Salva come JPEG
Categoria #
all - tutte 295.890
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 295.890
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021253 0 0 0 0 0 0 0 0 0 0 0 253
2021/20223.524 201 575 66 244 107 233 171 266 198 441 274 748
2022/20232.713 571 96 68 211 213 725 13 229 318 35 105 129
2023/20243.469 162 75 233 168 151 598 159 140 953 41 64 725
2024/20258.648 76 93 95 972 922 700 731 274 1.097 685 1.684 1.319
2025/202619.186 1.558 2.529 1.591 2.962 1.579 1.359 2.598 871 1.237 1.676 808 418
Totale 59.355